Renaissance Capital logo

PLRX News

US IPO Week Ahead: A flurry of launches forecasted to kick off December IPO blitz

DASH

Updated Monday, 11/30. Five IPOs and two SPACs are scheduled for the week ahead, with a wave of Monday morning launches kicking off the December IPO blitz as expected. Chinese education technology group 17 Education & Technology Group (YQ) plans to raise $288 million at a $2.2 billion market cap. The company's smart in-school classroom...read more

US IPO Week Ahead: Dun & Bradstreet returns to public market in shortened 4 IPO week

DNB

Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet (DNB). Dun & Bradstreet (DNB) plans to raise $1.3 billion at a market cap of $8 billion. The company was taken private for $6.9 billion including debt in February 2019 by an investor consortium led by Cannae Holdings,...read more

Fibrosis biotech Pliant Therapeutics prices IPO at $16 high end

PLRX

Pliant Therapeutics, a Phase 2 biotech developing therapies for the treatment of fibrosis, raised $144 million by offering 9.0 million shares at $16, the high end of the $14 to $16 range.  Earlier on Tuesday, Pliant filed an amendment adding 3.0 million shares to the offering, a 50% increase from the original deal size. Existing shareholder and collaboration partner...read more

This is the IPO market’s busiest week of the year with 8 deals on the calendar

WMG

IPOs are once again gaining steam and the calendar is flush with deals. With the IPO Index near all-time highs (tracked by NYSE: IPO), there are now eight offerings slated to price, making it the busiest week of the year. ...read more